Don't have Telegram yet? Try it now!
http://www.cardiobrief.org/2017/02/02/27000-patient-pcsk9-inhibitor-trial-meets-main-endpoints/
27,000 Patient PCSK9 Inhibitor Trial Meets Main Endpoints